Major Adverse Events with an LVAD: Patient-Reported Outcome Trajectory Changed
Left ventricular assist devices (LVAD) are being implanted at a higher rate than ever before to treat end stage heart failure, and are known to decrease mortality and increase quality of life (QOL) for patients. However, major adverse events, including major bleeding and infection (INTERMACS definitions), are common in patients with an LVAD. These events have great potential to impair patient experiences of living with an LVAD.The purpose of this analysis was to examine whether having a major adverse event would alter patient-reported outcomes over time, including depressive symptoms and QOL.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: J.H. Thompson, C.S. Lee Tags: (1274) Source Type: research
More News: Bleeding | Cardiology | Depression | Heart | Heart Failure | Heart Transplant | Lung Transplant | Transplant Surgery | Transplants